Updated September 29 at 4:29pm
Life Sciences
23 results total, viewing 1 - 10
The Slater Technology Fund on Monday announced it is committing another $250,000 to the biomedical company ProThera Biologics, bringing Slater’s total investment in the company to $950,000. more
Memorial Hospital and Women & Infants Hospital have received grant funds from the National Institutes of Health, as part of an NIH national initiative called Environmental Influences on Child Health Outcomes. more
Companies that remove snow, supply electricity to commercial customers and remove toxins from drinking water were among the 30 local enterprises that were recognized Wednesday night at Providence Business News’ fifth Fastest-Growing & Innovative Companies event, held at the Crowne Plaza Providence-Warwick. more
EpiVax Inc. has received a $600,000 grant from the National Institutes of Health through the Small Business Innovation Research program to improve a vaccine for the H7N9 avian influenza virus. more
The Slater Technology Fund has invested $50,000 in local water technology company HMSolution Inc. The company, co-founded by Brown University graduate and CEO Margaret Lengerich, has created technology designed to remove eight of the most common heavy metals in drinking water at a cost lower than traditional filtration methods more
Gov. Gina M. Raimondo on Thursday authorized development of the $45 million Garrahy parking garage, a project sought by the developer of a proposed life sciences and mixed use center on the Interstate 195 lands. more
Wexford Science & Technology LLC announced Thursday it has become an independent company, owned and operated by its existing management team, that will focus on managing and operating university-focused research and innovation districts. more
A ribbon cutting will be held for the new $68 million Richard E. Beaupre Center for Chemical and Forensic Sciences at the University of Rhode Island on Tuesday morning. more
Alexion Pharmaceuticals Inc. this morning hosted a groundbreaking ceremony for an expansion that is expected to double the size of its plant over the next five years. more
MindImmune Therapeutics Inc. will receive $500,000 in seed funding from Slater Technology Fund to support the drug discovery venture’s launch. more
1 | 2 | 3 Next »